Press release
Recent Study:Acquired (Autoimmune) Hemolytic Anemia to Represent an Impressive CAGR Throughout 2017 to 2025
Request to Sample of Report- https://www.persistencemarketresearch.com/samples/19732
Acquired (autoimmune) hemolytic anemia is non-genetic in nature and usually occurs when the body’s own immune system destroys its healthy tissues against invading organisms such as lymphocytes and antibodies. Acquired (autoimmune) hemolytic anemia generally occurs as a result or in conjunction with some other medical conditions. This condition rarely occurs alone. Acquired (autoimmune) hemolytic anemia can be classified as warm antibody hemolytic anemia and cold antibody hemolytic anemia. In warm antibody hemolytic anemia, auto-antibodies attach with the red blood cells and kill them at temperature higher than the body temperature; conversely, in cold antibody hemolytic anemia self-generated antibodies kill red blood cells at a temperature below the body temperature.
Diagnosis involves a range of blood tests such as hemoglobin and hematocrit test, bilirubin test, serum haptoglobin test and reticulocyte count. If the ratio is high, there is likeliness of hemolytic anemia. Coombs test is another key diagnostic method for acquired (autoimmune) hemolytic anemia in which the amount of certain antibodies is determined in order to check if it is higher than normal. Treatment is based on three major aims, preventing the destruction of RBCs, increasing the RBCs count and treating the origin of illness. Blood transfusion, medications, plasmapheresis and surgeries are among major treatment options. Prednisone, rituximab, hydroxyurea and cyclosporine are some drugs that are usually prescribed for treating acquired (autoimmune) hemolytic anemia.
There are no exact incidence and prevalence statistics are available regarding the acquired (autoimmune) hemolytic anemia. According to sources from Elsevier, Inc. the incidence rate of all types of acquired (autoimmune) hemolytic anemias range from one new case per 100,000 general population to 300,000 per year. Though the prevalence is not so high, severity of the condition will play a key role in driving the market growth. The market will also be driven by unmet medical needs as there is no standard medicines available for treating acquired hemolytic anemia. Many companies are conducting clinical trials in order to introduce effective medicines for acquired hemolytic anemia. Some major pharmaceutical companies and research institutions that are engaged in the development, manufacturing and marketing of drugs for this market include Novartis AG, Sanofi, Centre Hospitalier Universitaire Dijon, Institute of Hematology & Blood Diseases Hospital, Hoffmann-La Roche, National Cancer Institute (NCI), Agios Pharmaceuticals, Inc., Octapharma Pharmazeutika Produktionsges.m.b.H., National Heart, Lung, and Blood Institute (NHLBI) and Baxter Healthcare Corporation.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/19732
Geographically, the acquired (autoimmune) hemolytic anemia market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Globally, the market is led by North America, followed by Europe, Asia-Pacific and Rest of the World (RoW). High level of awareness, high per capita income and well established reimbursement scenario are among the major factors responsible for North America’s leading position in the acquired (autoimmune) hemolytic anemia market.
Pre Book Full Report –https://www.persistencemarketresearch.com/checkout/19732
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recent Study:Acquired (Autoimmune) Hemolytic Anemia to Represent an Impressive CAGR Throughout 2017 to 2025 here
News-ID: 887437 • Views: …
More Releases from Persistence Market Research
Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
The global smart door lock market is experiencing transformative growth as consumer demand for security, convenience, and smart home integration intensifies. The market size is projected to increase from US$ 3,059.7 Mn in 2025 to US$ 9,890.6 Mn by 2032, registering a robust CAGR of 18.3% during the forecast period. Rising concerns about home and workplace security, combined with rapid technological innovations, are fueling the adoption of smart door locks.…
Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand i …
The global Diisononyl Phthalate (DINP) market is undergoing a steady expansion, shaped by evolving industrial applications, regulatory dynamics, and technological innovations in plasticizers. As a key phthalate plasticizer, DINP is predominantly used in the production of flexible polyvinyl chloride (PVC) products. Its superior durability, flexibility, and resistance to weathering make it indispensable across a wide range of industries, from construction and automotive to consumer goods.
According to the latest study by…
Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand …
The global propylene carbonate market is entering a promising growth phase, fueled by rising demand across multiple industries, particularly in electronics, automotive, and paints & coatings. Propylene carbonate, a highly versatile organic compound, is widely recognized for its exceptional solvent properties, biodegradability, and low toxicity, making it a preferred choice in green chemistry applications.
According to the latest study by Persistence Market Research, the market is expected to grow from US$275.5…
Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
The Global Flexible Electronics Market is forecasted to expand at a CAGR of 11.4%, increasing from a value of US$ 2,762.0 million in 2023 to US$ 5,880.6 million by 2030. Flexible electronics is transforming the conventional electronics industry by integrating lightweight, bendable, and conformable devices into everyday life. These technologies are being widely adopted across consumer electronics, healthcare, automotive, and wearable technology sectors, promising increased portability, efficiency, and user-friendly designs.
Elevate…
More Releases for Acquired
Rising Incidence Of Hospital-Acquired Infections Fuels Growth In Hospital Acquir …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hospital Acquired Infections Testing Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for kits testing hospital-acquired infections has seen substantial growth in the recent past. The market, currently valued at $4.54 billion in 2024, is projected to expand to $4.83 billion…
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Hospital Acquired Disease Testing Market - Enhancing Patient Safety: Comprehensi …
Newark, New Castle, USA: The "Hospital Acquired Disease Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hospital Acquired Disease Testing Market: https://www.growthplusreports.com/report/hospital-acquired-disease-testing-market/7807
This latest report researches the…
SOS acquired by PracticeEvolve
Solicitors Own Software (SOS) have announced the sale of the business to PracticeEvolve Group to continue to provide the market with progressive technology, supported by strong service and support.
Operating since 1987, SOS have delivered practice and case management software and services to law firms across the UK. With over 17,000 users and a solid client base, Graham Colbourne, Managing Director, says the sale will ensure the market is provided…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets.
Report Consultant has introduced a new report titled as Global Pneumonia…
